Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × Taxes × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 7 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Fallopian Tube Neoplasms 5 Endometrial Neoplasms 5 Triple Negative Breast Neoplasms 4 Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Oropharyngeal Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Breast Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Adenocarcinoma of Lung 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Rectal Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Locally Advanced Cervical Adenocarcinoma 1 Gastric Adenocarcinoma 1

Interventions

pembrolizumab 29 Paclitaxel 12 Carboplatin 10 Cisplatin 7 Pemetrexed 5 Capecitabine 5 Saline Solution 4 Oxaliplatin 4 Gemcitabine 4 Fluorouracil 4 Docetaxel 4 Albumin-Bound Paclitaxel 4 patritumab deruxtecan 3 Leucovorin 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 olaparib 2 liposomal doxorubicin 2 lenvatinib 2 Irinotecan 2 Histamine H2 Antagonists 2 Histamine Antagonists 2 Glucose 2 Dexamethasone 2 Cetuximab 2 Acetaminophen 2 zanidatamab 1 trastuzumab deruxtecan 1 tislelizumab 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡